(Total Views: 138)
Posted On: 04/26/2017 9:01:00 AM
Post# of 7627

$ENTB Entest BioMedical's Chairman Discusses its Subsidiary, Zander Therapeutics, Inc.'s Progress With Small Molecule Immunotherapies for Treating Cancer and Arthritis in Dogs
https://www.otcmarkets.com/stock/ENTB/news
https://www.otcmarkets.com/stock/ENTB/news

